Trends in place of early-season influenza vaccination among adults, 2014–15 through 2018–19 influenza seasons – the importance of medical and nonmedical settings for vaccination

Publication date: Available online 7 October 2020Source: American Journal of Infection ControlAuthor(s): Peng-jun Lu, Anup Srivastav, Tammy A. Santibanez, Ashley Amaya, Jill A. Dever, Jessica Roycroft, Marshica Stanley Kurtz, Walter W. Williams
Source: American Journal of Infection Control - Category: Infectious Diseases Source Type: research

Related Links:

ConclusionsPatients on various solid tumour treatments achieve sero-protection rate congruent with the general population. The sero-protection HIA titres were not sustained at 24  weeks postvaccination.
Source: Supportive Care in Cancer - Category: Cancer & Oncology Source Type: research
CONCLUSIONS: Promoting asthma self-management education, influenza vaccinations, nebulizers, and spacers can decrease the frequency of healthcare utilization and asthma-related expenditures while improving medication adherence. PMID: 33031709 [PubMed - as supplied by publisher]
Source: Journal of Asthma - Category: Respiratory Medicine Tags: J Asthma Source Type: research
Publication date: Available online 7 October 2020Source: The Annals of Thoracic SurgeryAuthor(s): Rony Atoui, Fady Ebrahim F, Kevin Saroka, John Mireau, Janet E. McElhaney, Gregory Hare
Source: The Annals of Thoracic Surgery - Category: Cardiovascular & Thoracic Surgery Source Type: research
Kizzmekia Corbett joins TWiV to review her career and her work on respiratory syncytial virus, influenza virus, and coronaviruses and coronavirus vaccines, including her role in development and testing of a spike-encoding mRNA vaccine, and then we review the Nobel Prize for discovery of hepatitis C virus. Click arrow to playDownload TWiV 670 (76 MB .mp3, […]
Source: virology blog - Category: Virology Authors: Tags: This Week in Virology coronavirus COVID-19 influenza virus mRNA-1273 pandemic prefusion conformation respiratory syncytial virus SARS-CoV-2 spike vaccine viral viruses Source Type: blogs
Conditions:   Pregnancy Related;   Influenza Virus Vaccine Adverse Reaction Intervention:   Biological: influenza vaccine Sponsors:   Sungkyunkwan University;   Government-wide R&D Fund project for infectious disease research (GFID) Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
Condition:   Influenza Intervention:   Behavioral: The Impact of Performance Feedback and Variable Goal Setting on Flu Vaccination Success Rates of Providers Sponsors:   Kaiser Permanente;   London School of Economics and Political Science Completed
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
Conditions:   Pregnancy Related;   Influenza Virus Vaccine Adverse Reaction Intervention:   Biological: influenza vaccine Sponsors:   Sungkyunkwan University;   Government-wide R&D Fund project for infectious disease research (GFID) Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
Condition:   Influenza Intervention:   Biological: VRC-FLUNPF0103-00-VP VRC-FLUNPF0103-00-VP (H10ssF-6473) Sponsor:   National Institute of Allergy and Infectious Diseases (NIAID) Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
Condition:   Influenza Intervention:   Behavioral: The Impact of Performance Feedback and Variable Goal Setting on Flu Vaccination Success Rates of Providers Sponsors:   Kaiser Permanente;   London School of Economics and Political Science Completed
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
Condition:   Influenza Intervention:   Biological: VRC-FLUNPF0103-00-VP VRC-FLUNPF0103-00-VP (H10ssF-6473) Sponsor:   National Institute of Allergy and Infectious Diseases (NIAID) Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Infectious Diseases | Influenza | Influenza Vaccine | Vaccines